Increased concentration of lipoprotein(a) is a risk factor of coronary heart disease. lipoprotein(a) consists of LDL-like and highly polymorphic apolipoprotein(a). Here we studied the effect of lipoprotein(a)-containing sera with different apolipoprotein(a) phenotypes on lipid accumulation by THP-1 monocyte-like cells. Cholesterol concentration in lysates of THP-1 cells was significantly higher after their incubation with lipoprotein(a)-containing serum samples with low-molecular-weight phenotype of apolipoprotein(a) in comparison with samples with a high-molecular-weight apolipoprotein(a) phenotype irrespective of initial cholesterol level as well as serum concentrations of apoB-100, oxidized LDL, and circulating immune complexes. The presence of the most atherogenic small dense LDL subfractions in examined sera in addition to a low-molecular-weight apolipoprotein(a) phenotype resulted in significant elevation of cholesterol accumulation by THP-1 cells. The data obtained explain greater atherogenicity of lipoprotein(a) with low-molecular-weight apolipoprotein(a) phenotype.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-019-04452-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study.
Cardiovasc Diabetol
August 2024
Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland.
Background: Numerous observational studies have demonstrated that circulating lipoprotein(a) [Lp(a)] might be inversely related to the risk of type 2 diabetes (T2D). However, recent Mendelian randomization (MR) studies do not consistently support this association. The results of in vitro research suggest that high insulin concentrations can suppress Lp(a) levels by affecting apolipoprotein(a) [apo(a)] synthesis.
View Article and Find Full Text PDFGenetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.
J Am Heart Assoc
June 2024
Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital Icahn School of Medicine at Mount Sinai New York NY USA.
Elevated lipoprotein(a) is a genetically transmitted codominant trait that is an independent risk driver for cardiovascular disease. Lipoprotein(a) concentration is heavily influenced by genetic factors, including kringle IV-2 domain size, single-nucleotide polymorphisms, and interleukin-1 genotypes. Apolipoprotein(a) is encoded by the gene and contains 10 subtypes with a variable number of copies of kringle -2, resulting in >40 different apolipoprotein(a) isoform sizes.
View Article and Find Full Text PDFAssessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods.
Int J Mol Sci
September 2023
Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.
Apolipoprotein(a) (apo(a)) is the protein component that defines lipoprotein(a) (Lp(a)) particles and is encoded by the LPA gene. The apo(a) is extremely heterogeneous in size due to the copy number variations in the kringle-IV type 2 (KIV2) domains. In this review, we aim to discuss the role of genetics in establishing Lp(a) as a risk factor for coronary heart disease (CHD) by examining a series of molecular biology techniques aimed at identifying the best strategy for a possible application in clinical research and practice, according to the current gold standard.
View Article and Find Full Text PDFHigh levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner.
Atherosclerosis
November 2023
Robarts Research Institute, Schulich School of Medicine & Dentistry, London, Ontario, Canada; Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Ontario, N6A 5B7, Canada. Electronic address:
Article Synopsis
- The study explores the role of lipoprotein(a) (Lp(a)) in atherosclerotic cardiovascular disease by creating transgenic mice that express human apolipoprotein(a) and apoB-100 to achieve higher plasma Lp(a) levels, addressing limitations of previous models.
- After feeding these mice a high-fat, high-cholesterol diet for 12 weeks, researchers observed significant differences in plaque size and composition, particularly in female Tg(LPA;APOB) mice, who showed increased necrotic core size and more extensive calcification compared to control mice.
- The findings indicate that elevated Lp(a) correlates with more severe atherosclerosis, as evidenced by greater levels of pro-inflammatory markers and
Correlation between genetic polymorphisms in apolipoprotein E and atrial fibrillation.
Rev Port Cardiol
May 2022
Department of Cardiovascular Medicine, The First Affiliated Hospital of Soochow University, Soochow, China. Electronic address:
This work explores correlations between genetic polymorphisms in apolipoprotein E (ApoE) and atrial fibrillation (AF). We detected polymorphisms in the APOE gene in 64 patients with AF and 49 non-AF volunteers at the Department of Cardiology of Lianyungang Second People's Hospital between July 2017 and July 2019. We found significant differences in age, body mass index, left atrial diameter, and left ventricular ejection fraction between the two groups.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!